All research files

Growth & hormones / RESEARCH PROTOCOL GUIDE

Tesamorelin

Growth & hormones · Research protocol guide

Growth hormone-releasing factor analog studied for excess abdominal fat in HIV-associated lipodystrophy.

Catalog provenance checked October 18, 2026Independent research dossier

01 / RESEARCH SUMMARY

Tesamorelin Research Summary

Tesamorelin is a stabilized analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary to release growth hormone and raises IGF-1. It is FDA-approved as Egrifta to reduce excess abdominal fat in people with HIV-associated lipodystrophy, where trials showed about 15–18% reductions in visceral fat. It has also been studied for reducing liver fat in fatty liver disease.

Read the full guide →

02 / WHY RESEARCHERS STUDY IT

Why Tesamorelin draws research interest

These are the areas researchers and the peptide community explore Tesamorelin for most often. They describe what is being studied — not proven benefits, approved uses, or promised results.

Visceral fat

FDA-approved as Egrifta; cut visceral fat about 15–18%.

Liver fat

Studied for reducing liver fat in fatty liver disease.

IGF-1

Raises IGF-1 through natural GH release.

Evidence ranges from early lab work to large clinical trials depending on the use — see the sections below for the data and sources.

03 / DOSING & RECONSTITUTION

Dosing & Reconstitution Guide

A single practical dilution with accurate dosing, step by step

Standard Approach (3 mL = 3.33 mg/mL)

  • Reconstitute: Add 3 mL bacteriostatic water to one 10 mg vial → final concentration 3.33 mg/mL (3,333.3 mcg/mL).
  • Typical range: 0.5–2 mg 1x daily am/pm · 5 on 2 off or daily, 3–6 months · fasted.
  • Easy measuring: At 3.33 mg/mL, 1 unit ≈ 33.33 mcg on a U-100 syringe, so doses read at 15–60 units.
  • Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the mixed solution.
ProtocolDose rangeFrequencyCycleTime offHalf-lifeFastedRoute
Injectable · Subq0.5–2 mg1x daily AM/PM · 5 on 2 off or daily3–6 months4–8 weeks~26–38 minYesSubq
HIV-associated abdominal fat · randomized trial (2007)2 mgOnce daily26 weeksSubcutaneous (historical study formulation)

04 / RECONSTITUTION CALCULATOR

Mix & measure Tesamorelin · 10 mg

Pre-filled with this protocol's recommended BAC water and starting dose — edit any field to run your own numbers.

CONCENTRATION
3.33 mg/mL
DRAW VOLUME
0.150 mL
ON THE SYRINGE
15.0 units
DOSES / VIAL
20
15 units0102030405060708090100

Reconstitution math only. U-100 syringe: 100 units = 1 mL.

Reconstitution GuideFull calculator →

05 / STORAGE

Storage Instructions

Lyophilized (powder)

Store in the freezer at −20 °C (−4 °F) for long-term storage, or refrigerated at 2–8 °C for shorter periods. Keep dry, sealed and away from light. Let a frozen vial reach room temperature before opening to avoid condensation.

Reconstituted

Refrigerate at 2–8 °C (35.6–46.4 °F) and use within about 28 days. Do not freeze. Keep away from heat and direct light, and avoid repeated temperature swings. Swirl gently — never shake.

Reconstitution steps

  1. Wipe the vial stopper with an alcohol swab.
  2. Draw the BAC water and release it slowly down the inside wall of the vial.
  3. Swirl or roll gently until fully dissolved — don't shake.
  4. Label with the date and concentration and refrigerate.
Read the full Reconstitution Guide →

06 / RESEARCH FINDINGS

What Research Shows

Human research

  • A randomized trial evaluated reduction in visceral abdominal adipose tissue in people with HIV and excess abdominal fat.
  • Growth hormone-releasing factor signaling and metabolic outcomes were studied; this is not evidence for general weight loss or bodybuilding.
Research context

The community-provided Tesa mapping does not verify the vendor vial. Historical study doses and current licensed formulations are not interchangeable.

07 / MOLECULAR BIOLOGY

Mechanism of Action

Characterized biological pathway

Growth hormone-releasing hormone receptor

Activates pituitary GHRH receptors to stimulate growth hormone release, with downstream effects on IGF-1 and metabolism. This is distinct from directly administering growth hormone.

Adamantane & the blood–brain barrier

Chemically attaching an adamantane group to a peptide can increase its lipid (fat) solubility. Researchers hypothesize that this modification may help certain compounds cross the tightly regulated blood–brain barrier. The effect depends on the specific modified molecule; greater lipid solubility alone does not establish brain delivery or clinical benefit. This does not apply automatically to the unmodified peptide and is not a reconstitution additive.

08 / LIFESTYLE FACTORS

Lifestyle Factors

  • Sleep: aim for 7–9 hours; the largest natural GH pulse happens in deep sleep.
  • Fasted dosing: dose away from meals — elevated insulin and carbs blunt the GH pulse.
  • Training: pair with resistance training and real recovery days.
  • Protein: keep protein intake adequate to support lean mass.
  • Consistency: dose at the same time each day and rotate injection sites.

09 / BENEFITS & SIDE EFFECTS

Potential Benefits & Side Effects

Potential Benefits

  • Deeper, more restorative sleep
  • Improved recovery from training
  • Gradual improvements in body composition (more lean mass, less fat)
  • Better skin, hair and overall vitality reported over longer cycles

Side Effects

  • Injection-site redness or irritation
  • Water retention, tingling or numbness in hands
  • Head rush, flushing or lightheadedness shortly after dosing
  • Increased hunger (more with ghrelin-pathway peptides)
  • Higher blood sugar at larger doses — monitor glucose and IGF-1

10 / STUDIES

Studies & references

11 / SAFETY

Safety considerations

  • Verify the active identity, lot number, and matching certificate of analysis. Testing does not by itself establish sterility or suitability for human use.
  • Follow documented product-specific storage and preparation requirements; stability and diluent compatibility depend on the formulation.
  • Research powders are not interchangeable with prescription formulations. Do not infer an injection or nasal protocol from a concentration calculation.
  • For medical care, pregnancy, existing conditions, or medication interactions, consult a qualified healthcare professional.

12 / RECOMMENDED SOURCE

Recommended Source

For research peptides, we point researchers to Orbitrex Peptides for Tesamorelin.

Why Orbitrex?

  • Family-owned & independently tested: Multiple laboratories verify quality, with batch-specific testing in every COA.
  • Everyday value: Buy 4, Get 1 Free on eligible products.
  • Loyalty credit: 5% back in loyalty credit for future purchases.
  • VerifyPass discount: 20% off for qualifying groups — stacks with affiliate codes.
  • Free 2nd Day shipping: Free UPS 2nd Day Air on orders $200+, applied automatically at checkout.

All products are for research use only. Availability and offers subject to change.